Paper17200715
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.
MacArthur JM and 6 others. J Clin Invest, 2007. Cited by 169 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. Papers, record 17200715. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17200715
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Heparan Sulfate Proteoglycans | Major topic |
| Lipoproteins | Major topic |
| Liver | Major topic |
| Receptors, LDL | Major topic |
| Triglycerides | Major topic |
| Apolipoproteins E | |
| Fibroblast Growth Factor 2 | |
| Hepatocytes | |
| Humans | |
| Hypertriglyceridemia |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R37 GM033063 | NIGMS NIH HHS | United States | R01GM033063 | PubMed and NIH | NIH RePORTER |
| R01 GM033063 | NIGMS NIH HHS | United States | R01GM033063 | PubMed and NIH | NIH RePORTER |
| HL56989 | NHLBI NIH HHS | United States | P50HL056989 | PubMed and NIH | NIH RePORTER |
| HL57345 | NHLBI NIH HHS | United States | P01HL057345 | PubMed and NIH | NIH RePORTER |
| P50 HL056989 | NHLBI NIH HHS | United States | P50HL056989 | PubMed and NIH | NIH RePORTER |
| P01 HL057345 | NHLBI NIH HHS | United States | P01HL057345 | PubMed and NIH | NIH RePORTER |
| GM33063 | NIGMS NIH HHS | United States | R01GM033063 | PubMed and NIH | NIH RePORTER |
| R37GM033063 | NIH | NIH RePORTER |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 17200713 | Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. | https://conductscience.org/library/papers/17200713 | PubMed |
| Comment in | 17393511 | Liver heparan sulfate proteoglycans: old molecules provide new insights on lipoprotein metabolism. | https://conductscience.org/library/papers/17393511 | PubMed |
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9634821 | Sustained somatic gene inactivation by viral transfer of Cre recombinase. | Nat Biotechnol | 1996 | https://conductscience.org/library/papers/9634821 | PubMed |
| 2 | 3523161 | Preparation, characterization, and measurement of lipoprotein lipase. | Methods Enzymol | 1986 | https://conductscience.org/library/papers/3523161 | PubMed |
| 3 | 2170353 | The unstirred water layer as a site of control of apolipoprotein B secretion. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2170353 | PubMed |
| 4 | 14605369 | Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. | Science | 2003 | https://conductscience.org/library/papers/14605369 | PubMed |
| 5 | 10862796 | Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10862796 | PubMed |
| 6 | 15296698 | Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. | Curr Atheroscler Rep | 2004 | https://conductscience.org/library/papers/15296698 | PubMed |
| 7 | 10818109 | Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10818109 | PubMed |
| 8 | 12509515 | Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12509515 | PubMed |
| 9 | 9392416 | Hepatic uptake of chylomicron remnants. | J Lipid Res | 1997 | https://conductscience.org/library/papers/9392416 | PubMed |
| 10 | 1533636 | Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic, and intracellular degradative pathways. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1533636 | PubMed |
| 11 | 16056228 | Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16056228 | PubMed |
| 12 | 10872465 | Functions of cell surface heparan sulfate proteoglycans. | Annu Rev Biochem | 1999 | https://conductscience.org/library/papers/10872465 | PubMed |
| 13 | 16782967 | Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16782967 | PubMed |
| 14 | 9335533 | Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. | Biochemistry | 1997 | https://conductscience.org/library/papers/9335533 | PubMed |
| 15 | 9518150 | Sensitive high-performance liquid chromatographic method with fluorometric detection for the determination of heparin and heparan sulfate in biological samples: application to human urinary heparan sulfate. | J Chromatogr B Biomed Sci Appl | 1997 | https://conductscience.org/library/papers/9518150 | PubMed |
| 16 | 11522680 | Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. | Diabetes | 2001 | https://conductscience.org/library/papers/11522680 | PubMed |
| 17 | 11500500 | New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11500500 | PubMed |
| 18 | 9186917 | Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. | J Lipid Res | 1997 | https://conductscience.org/library/papers/9186917 | PubMed |
| 19 | 9294130 | The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9294130 | PubMed |
| 20 | 11342582 | Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11342582 | PubMed |
Cited by107
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 169 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42660998 | Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy. | Nat Rev Cardiol | 2026 | https://conductscience.org/library/papers/42660998 | PubMed |
| 41673170 | Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/41673170 | PubMed |
| 40605748 | LDL-Bound PCSK9 Has a Slower Clearance Kinetic and Higher Use for HSPGs Than Free-PCSK9-Brief Report. | Arterioscler Thromb Vasc Biol | 2025 | https://conductscience.org/library/papers/40605748 | PubMed |
| 40512794 | Bruch's membrane heparan sulfate retains lipoproteins in the early stages of age-related macular degeneration. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40512794 | PubMed |
| 40500442 | Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis. | Nature | 2025 | https://conductscience.org/library/papers/40500442 | PubMed |
| 40093586 | Heparan sulfate chains in hepatocellular carcinoma. | Gastroenterol Rep (Oxf) | 2025 | https://conductscience.org/library/papers/40093586 | PubMed |
| 39871348 | Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications. | Mol Neurodegener | 2025 | https://conductscience.org/library/papers/39871348 | PubMed |
| 39588647 | Tale of 2 Receptors. | Arterioscler Thromb Vasc Biol | 2025 | https://conductscience.org/library/papers/39588647 | PubMed |
| 39087348 | Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice. | Arterioscler Thromb Vasc Biol | 2024 | https://conductscience.org/library/papers/39087348 | PubMed |
| 38540127 | Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540127 | PubMed |
| 37972731 | Apolipoprotein C3: form begets function. | J Lipid Res | 2024 | https://conductscience.org/library/papers/37972731 | PubMed |
| 36986536 | Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986536 | PubMed |
| 36768377 | Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768377 | PubMed |
| 36699460 | Regulation of autophagy, lipid metabolism, and neurodegenerative pathology by heparan sulfate proteoglycans. | Front Genet | 2022 | https://conductscience.org/library/papers/36699460 | PubMed |
| 35992575 | N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19. | Adv Pharmacol Pharm Sci | 2022 | https://conductscience.org/library/papers/35992575 | PubMed |
| 35653195 | Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering. | JCI Insight | 2022 | https://conductscience.org/library/papers/35653195 | PubMed |
| 35329997 | Heparanase Inhibition Prevents Liver Steatosis in E0 Mice. | J Clin Med | 2022 | https://conductscience.org/library/papers/35329997 | PubMed |
| 35216081 | Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216081 | PubMed |
| 34619025 | Diet-induced prediabetes: Effects on the activity of the renin-angiotensin-aldosterone system in selected organs. | J Diabetes Investig | 2022 | https://conductscience.org/library/papers/34619025 | PubMed |
| 33842343 | The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges. | Front Oncol | 2021 | https://conductscience.org/library/papers/33842343 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17200715
GET https://conductscience.org/api/papers/v1/17200715/references?page=2